Italy Pharmaceuticals & Healthcare Report Q3 2013 - New Market Research Report
The sharp drop in public pharmaceutical expenditure in Italy in 2012 to a level below that of 2001 does not bode well for drugmakers and pharmacies in the country. The success of the implemented policies may encourage the enforcement of further cost-containment measures, which, together with the ongoing public hospital debt situation, seriously hampers the country's attractiveness as a location in which to sell drugs, despite its favourable demographic characteristics.
View full press release